Real world treatment patterns, time to next treatment and economic outcomes in relapsed multiple myeloma patients treated with pomalidomide or carfilzomib.

被引：0
|
作者：
Parikh, Kejal
Purnomo, Lea
Abouzaid, Safiya
Chen, Chi-Chang
McGuiness, Catherine Balderston
Hussein, Mohamad A.
Wade, Rolin L.
机构：
[1] Celgene Corp, Summit, NJ USA
[2] IMS Hlth, Plymouth Meeting, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.8042
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8042
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Real-World Treatment Patterns, Time to Next Treatment, and Economic Outcomes in Relapsed or Refractory Multiple Myeloma Patients Treated with Pomalidomide or Carfilzomib
    Chen, Chi-Chang
    Parikh, Kejal
    Abouzaid, Safiya
    Purnomo, Lea
    McGuiness, Catherine B.
    Hussein, Mohamed
    Wade, Rolin L.
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2017, 23 (02): : 236 - 236
  • [2] POMALIDOMIDE OR CARFILZOMIB USE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA: REAL-WORLD TREATMENT PATTERNS, TIME TO NEXT TREATMENT, AND ECONOMIC OUTCOMES
    Parikh, K.
    Purnomo, L.
    Abouzaid, S.
    Chen, C. C.
    McGuiness, C.
    Hussein, M.
    Wade, R.
    [J]. HAEMATOLOGICA, 2016, 101 : 603 - 603
  • [3] Real-world treatment patterns in relapsed/refractory multiple myeloma: Clinical and economic outcomes in patients treated with pomalidomide or daratumumab
    Richter, Joshua
    Anupindi, Vamshi Ruthwik
    Yeaw, Jason
    Kudaravalli, Suneel
    Zavisic, Stojan
    Shah, Drishti
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (02) : 395 - 409
  • [4] Sequence Impact Of Pomalidomide and Carfilzomib On Treatment Response In Relapsed Multiple Myeloma
    Mark, Tomer M.
    Allan, John N.
    Boyer, Angelique
    Rossi, Adriana C.
    Pearse, Roger N.
    Zafar, Faiza
    Pekle, Karen
    Tegnestam, Linda
    Jayabalan, David
    Coleman, Morton
    Niesvizky, Ruben
    [J]. BLOOD, 2013, 122 (21)
  • [5] Current Real-World Treatment Patterns and Outcomes in Patients with Relapsed/Refractory Multiple Myeloma
    Willson, Jenny
    Bruno, Amanda
    Opalinska, Joanna
    Nelson, Jeannene
    Lunacsek, Orsolya
    Stafkey-Mailey, Dana
    Willey, Joanne
    [J]. BLOOD, 2018, 132
  • [6] Real-World Practice Patterns with Carfilzomib in Patients with Relapsed and Refractory Multiple Myeloma
    Harvey, R. Donald
    Cong, Ze
    Werther, Winifred
    Lethen, Jan L.
    Lonial, Sagar
    [J]. BLOOD, 2014, 124 (21)
  • [7] Assessing the Effect of Pomalidomide or Carfilzomib Treatment on Patient-Reported Outcomes Among Patients With Relapsed/Refractory Multiple Myeloma
    Gupta, Shaloo
    Clancy, Zoe
    Copher, Ronda
    Rosenberg, Aaron Seth
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E268 - E269
  • [8] Pomalidomide in the treatment of relapsed multiple myeloma
    Forsberg, Peter A.
    Mark, Tomer M.
    [J]. FUTURE ONCOLOGY, 2013, 9 (07) : 939 - 948
  • [9] Recent real-world treatment patterns and outcomes in US patients with relapsed/refractory multiple myeloma
    Bruno, Amanda S.
    Willson, Jenny L.
    Opalinska, Joanna M.
    Nelson, Jeanenne J.
    Lunacsek, Orsolya E.
    Stafkey-Mailey, Dana R.
    Willey, Joanne P.
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2020, 13 (09) : 1017 - 1025
  • [10] Current real-world treatment patterns and outcomes in patients with relapsed/refractory multiple myeloma.
    Willson, Jenny
    Bruno, Amanda
    Opalinska, Joanna
    Nelson, Jeanenne Joy
    Lunacsek, Orsolya
    Stafkey-Mailey, Dana
    Willey, Joanne P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345